The Potential of Wearable Devices in Cancer Care Delivery

Ce dossier présente deux études, l'une évaluant un dispositif portable mesurant le nombre de pas quotidiens et permettant, à l'aide de l'intelligence artificielle, de prédire le risque d'hospitalisation pendant la chimioradiothérapie, et l'autre évaluant l'intérêt de mesurer objectivement l'activité physique pour prédire la survie chez les patients atteints d'un cancer

Résumé en anglais

Wearable devices, or devices worn on the bodies of patients such as the Apple Watch, FitBit, or other monitoring devices, offer opportunities to innovate and improve cancer care delivery, from prevention and screening through survivorship. Fueled partly by the COVID-19 pandemic and growing need for remote and virtual care, the number of studies of technology-supported health interventions in cancer— including studies on wearables in cancer care—has increased dramatically in the past 3 to 5 years.1,2 These studies underscore the potential offered by wearable devices across the landscape of cancer care delivery. Wearable devices may be used to support a range of activities including real-time monitoring of patient data, such as heart rate, blood pressure, or sleep quality, as well as allowing patients to directly report symptoms and mood using the wearable device. This allows for more accurate and ongoing health-related data collection for patients that can be used to manage and adjust treatment and to predict the potential for negative outcomes such as hospitalization. Integrating wearable devices into cancer care delivery holds promise for improving outcomes for patients across the care continuum.

Full Text